Market Tracker

08/26 5:16pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

96.22
Delayed Data
As of Aug 26
 +1.25 / +1.32%
Today’s Change
62.12
Today|||52-Week Range
136.85
-8.15%
Year-to-Date

Today’s Trading

Previous close94.97
Today’s open95.09
Day’s range94.42 - 96.36
Volume1,294,891
Average volume (3 months)1,752,966
Market cap$16.4B
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-16.30%
Earnings growth (this year)-275.75%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+16.29%
P/E ratioNM
Price/Sales19.22
Price/Book6.47

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+0.94+1.17%
MDVNMedivation Inc+0.11+0.14%
PRGOPerrigo Company PLC+0.13+0.15%
VRXValeant Pharmaceutic...-0.26-0.84%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$872.2M
Annual profit (last year)-$171.8M
Net profit margin-19.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts